default author photo

Saskia K. Klein

Meander Medical Center - Department of Hematology

Netherlands

SCHOLARLY PAPERS

2

DOWNLOADS

171

TOTAL CITATIONS

4

Scholarly Papers (2)

1.

Health-Related Quality of Life in Transplant Ineligible Newly Diagnosed Multiple Myeloma Patients Treated with Either Thalidomide or Lenalidomide-Based Regimen Until Progression (HOVON-87/NMSG18 Study): A Prospective, Open-Label, Multicenter, Randomized, Phase 3 Study

Number of pages: 89 Posted: 25 Feb 2019
Odense University Hospital - Quality of Life Research Center, VU University Amsterdam, VU University Amsterdam, Erasmus University Rotterdam (EUR) - Clinical Trial Center, South Elvsborg Hospital, University of Copenhagen - Rigshospitalet, Maastricht University, Medical Center, Department of Hematology, Albert Schweitzer Hospital - Department of Internal Medicine, Erasmus University Rotterdam (EUR) - Cancer Institute, Lund University - Skane University Hospital, Martini Ziekenhuis, Tergooi Hospital, Isala Zwolle, Vejle Hospital, Meander Medical Center - Department of Hematology, Forde Central Hospital, Northwest Clinics, Maasstad Hospital, Jeroen Bosch Hospital - Department of Hematology, University of Stavanger - Stavanger University Hospital, Zaans Medisch Centrum, University of Copenhagen - Rigshospitalet, VU University Amsterdam - Department of Hematology, Erasmus University Rotterdam (EUR) - Department of Hematology, Norwegian University of Science and Technology (NTNU), Odense University Hospital and VU University Amsterdam - Department of Hematology
Downloads 109 (645,052)

Abstract:

Loading...

Health-Related Quality of Life, Multiple Myeloma, Clinical Trial

2.

Improved Survival with Thalidomide Before and after Autologous Stem Cell Transplantation in Newly Diagnosed Multiple Myeloma: Long-Term Results from the HOVON-50 Study

Number of pages: 102 Posted: 27 Jul 2018
VU University Amsterdam - Department of Hematology, Erasmus University Rotterdam (EUR) - Clinical Trial Center, Utrecht University, University Medical Center, Cancer Center, Department of Hematology, University of Groningen - Department of Hematology and Oncology, Radboud University Nijmegen - Department of Hematology, University of Amsterdam, Academic Medical Center, Department of Hematology, Leiden University, Medical Center (LUMC), Department of Hematology, Haga Hospital - Department of Hematology, Medisch Spectrum Twente - Department of Hematology, St. Antonius Ziekenhuis - Department of Hematology, Meander Medical Center - Department of Hematology, KU Leuven, Faculty of Medicine, Department of Hematology, Albert Schweitzer Hospital - Department of Internal Medicine, Maastricht University, Medical Center, Department of Hematology, Zuyderland Medical Center - Department of Hematology, Jeroen Bosch Hospital - Department of Hematology, Isala Zwolle - Department of Hematology, Medical Center Leeuwarden - Department of Hematology, VU University Amsterdam - Department of Hematology, Erasmus University Rotterdam (EUR) - Department of Hematology and VU University Amsterdam - Department of Hematology
Downloads 62 (951,658)
Citation 4

Abstract:

Loading...

multiple myeloma, randomized phase 3, thalidomide, newly diagnosed, autologous stem cell transplantation